ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
MedTech Acquisition Corporation

MedTech Acquisition Corporation (MTAC)

11,34
0,00
(0,00%)
Beim Schlusskurs: 03 Dezember 10:00PM
11,34
0,00
( 0,00% )
Nach Börsenschluss: -

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
11,34
Gebot
11,30
Fragen
11,94
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Handelsende
11,34
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
1.953.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,35
Gewinn pro Aktie (EPS)
-32,4
Erlöse
18,51M
Nettogewinn
-63,28M

Über MedTech Acquisition Corporation

MedTech Acquisition Corp is a blank check company. MedTech Acquisition Corp is a blank check company.

Sektor
Surgical,med Instr,apparatus
Branche
Blank Checks
Hauptsitz
Wilmington, Delaware, USA
Gegründet
2023

MTAC Neueste Nachrichten

MedTech Acquisition Corporation Adjourns Special Meeting of Stockholders

MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or the “Company”) today announced that it convened and then adjourned, without conducting any business, its special meeting of...

TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual Meeting

New data from PERIO-01 clinical trial indicates PEDD™ method resulted in modulation of the tumor microenvironment and decreased circulating tumor DNA (ctDNA) levels TriSalus Life Sciences® Inc...

TriSalus Life Sciences Presents New Data at AACR for SD-101 Delivered by the Proprietary PEDD™ Method in Stage IV Uveal Melanoma Patients With Liver Metastases

TriSalus Life Sciences® Inc., (“TriSalus” or the “Company”), an oncology company in the process of going public through a business combination transaction (the “Business Combination”) with...

TriSalus Life Sciences Appoints James Alecxih to Lead Device Technology Business

TriSalus Life Sciences®, Inc. (“TriSalus” or the “Company”), an oncology company in the process of going public through a business combination transaction (the “Business Combination”) with...

MedTech Acquisition Corporation Announces Adjournment of its Special Meeting in lieu of an Annual Meeting of Stockholders

The Company recommends all of its stockholders to vote FOR the Extension Amendment at the upcoming Special Meeting. New York, NY, Dec. 07, 2022 (GLOBE NEWSWIRE) -- MedTech Acquisition...

MedTech Acquisition Corporation and Memic Innovative Surgery Ltd. Mutually Agree to Terminate Business Combination

TEL AVIV, Israel and FORT LAUDERDALE, Fla., March 10, 2022 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech”), a publicly traded special purpose acquisition company...

Memic Announces Adoption of Hominis® Surgical System at Three Leading U.S. Hospitals in Q4 2021

Memic Announces Adoption of Hominis® Surgical System at Three Leading U.S. Hospitals in Q4 2021 HCA Florida Healthcare's Kendall Regional Medical Center, AdventHealth Celebration and The Women's...

Memic Announces Robert L. Ryan and Sandra Morgan to Join Board of Directors Upon Closing of Business Combination with MedTech Acquisition Corporation

Memic Announces Robert L. Ryan and Sandra Morgan to Join Board of Directors Upon Closing of Business Combination with MedTech Acquisition Corporation Industry veterans with leadership experience...

Peregrine Ventures Portfolio Company Memic Announces $1B Valuation SPAC deal

Peregrine Ventures Portfolio Company Memic Announces $1B Valuation SPAC deal PR Newswire OR YEHUDA, Israel, Aug. 19, 2021 OR YEHUDA, Israel, Aug. 19, 2021 /PRNewswire/ -- Peregrine Ventures...

Memic Innovative Surgery Ltd. and MedTech Acquisition Corporation Announce Proposed Business Combination

Memic Innovative Surgery Ltd. and MedTech Acquisition Corporation Announce Proposed Business Combination - Memic's Hominis® platform is the first and only FDA-authorized surgical robot that...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
HTOOFusion Fuel Green PLC
US$ 0,5433
(70,85%)
10,1M
HRTXHeron Therapeautics Inc
US$ 1,79
(51,69%)
1,15M
VIRXViracta Therapeutics Inc
US$ 0,2034
(24,94%)
5,26M
OKTAOkta Inc
US$ 96,2606
(17,81%)
2,23M
RITRReitar Logtech Holdings Ltd
US$ 3,05
(13,81%)
13,34k
ORISOriental Rise Holdings Ltd
US$ 7,0053
(-41,38%)
323,95k
TRVITrevi Therapeutics Inc
US$ 2,15
(-22,66%)
69,1k
NOTVInotiv Inc
US$ 3,55
(-15,27%)
41,75k
LUNRIntuitive Machines Inc
US$ 12,17
(-13,99%)
3,04M
BASECouchbase Inc
US$ 18,52
(-12,31%)
55,33k
HTOOFusion Fuel Green PLC
US$ 0,5433
(70,85%)
10,1M
NVDANVIDIA Corporation
US$ 140,59
(0,24%)
5,73M
VIRXViracta Therapeutics Inc
US$ 0,2034
(24,94%)
5,26M
LUNRIntuitive Machines Inc
US$ 12,17
(-13,99%)
3,04M
BILIBilibili Inc
US$ 19,21
(-0,10%)
2,55M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock